Burning Rock of Guangzhou Raises $23 Million for Diagnostic Products

Burning Rock Biotech, a Guangzhou oncology diagnostics company, completed a $23 million Series A+ round of funding. The company is developing diagnostic tests for solid tumor cancers that indicate the best treatment option for each patient. Investors in the round include Jifeng Capital, Sequoia Capital and Legend Star. Founded in March 2014, Burning Rock raised $9.7 million in the Series A round last year from Northern Light Venture Capital and Legend Star, an incubator program of Legend Holdings More details.... Share this with colleagues: // //